Phreesia Inc

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Phreesia reports strong Q1 earnings, sees growth in Medicare market

Phreesia's Q1 2023 earnings call highlighted strong performance, maintained revenue outlook, and raised adjusted EBITDA outlook. The company faces challenges from labor market changes and pricing experimentation but sees opportunities in product growth, client adds, and patient insights application.

Phreesia reports strong Q2 2024 earnings and strategic acquisitions

Phreesia's Q2 2024 performance reflects strong revenue growth and strategic outlook, despite challenges related to client adds and subscription revenue. The company's focus on achieving profitability beyond fiscal 2025 and strategic acquisitions positions it for long-term value creation. Balancing growth and investment, as well as navigating seasonality and external events, are key considerations for Phreesia's future.

Phreesia reports Q3 2024 revenue of $91.6 million, delays revenue target to prioritize EBITDA growth

Phreesia's Q3 2024 earnings call highlighted strong revenue performance, an acquisition enhancing patient experience, and a strategic decision to delay revenue targets to prioritize EBITDA growth. The company maintains a focus on innovation, customer satisfaction, and sustainable financial performance, while also addressing short-term financial challenges and positioning for significant revenue and profitability growth in fiscal 2025.

Phreesia reports robust Q4 earnings, eyes growth in healthcare solutions

Phreesia Inc's Q4 2023 performance reflects strong revenue growth and client base expansion, positioning the company for future profitability and stability.
With a focus on client value, strategic acquisitions, and operational efficiency, Phreesia navigates challenges in the healthcare industry to drive long-term growth.
Opportunities in network solutions, payer space, and margin improvement present avenues for Phreesia to capitalize on market trends and enhance shareholder value.

Phreesia Inc reports strong Q1 earnings, eyes revenue growth

Phreesia Inc's Q1 2024 performance reflects robust revenue growth and client expansion, with a positive outlook for fiscal 2024 and ambitious targets for fiscal 2025.
While facing challenges such as potential growth deceleration and labor market impacts, the company remains focused on innovation, client satisfaction, and profitability.
Opportunities in new revenue streams, partnerships, and payment technologies present avenues for Phreesia to drive future growth and market leadership.

Phreesia Inc reports robust Q2 performance and targets fiscal growth

Phreesia Inc's Q2 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic targets for fiscal 2024 and 2025, underpinned by investments in client value and growth strategies.
While facing challenges in the sales cycle and cost controls, the company remains focused on achieving profitability and free cash flow without additional capital beyond fiscal '25.
Opportunities in product introductions, customer service enhancements, and market expansion present avenues for sustained growth and value creation for Phreesia.

Phreesia reports robust Q3 performance, shifts focus to profitability

Phreesia Inc's Q3 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic acquisitions, underlining the company's positive trajectory.
While facing challenges in achieving profitability and managing investor expectations, Phreesia's focus on financial discipline and market expansion presents opportunities for sustainable growth.
The establishment of a new credit facility and clear guidance for fiscal 2024 and 2025 demonstrate Phreesia's commitment to financial stability and long-term value creation.

Phreesia reports strong Q4 revenue growth and focuses on profitability

Phreesia Inc's Q4 performance reflects revenue growth and improved EBITDA, with a focus on efficiency and client value to drive profitability.
Despite industry challenges, Phreesia's strengths in client growth strategies, network solutions revenue, and cash flow support its growth trajectory.
Balancing profitability goals with investments in growth, Phreesia navigates challenges while exploring opportunities in PAM, client value, and network expansion.
The company's outlook for FY 2025 underscores a commitment to sustainable growth through client additions, product enhancements, and operational efficiency.

Phreesia Inc reports strong Q1 earnings, eyes growth opportunities

Phreesia Inc's Q1 performance reflects a positive turnaround with revenue growth and adjusted EBITDA turning positive after 3 years. The company faces challenges from client relationship transitions but is leveraging opportunities in cybersecurity investments and revenue-driving products.

Phreesia Inc reports robust Q2 earnings and optimistic outlook

Phreesia Inc's Q2 2025 earnings call highlighted strong financial performance and positive outlook for fiscal 2025. While facing uncertainties around external factors and inorganic opportunities, the company remains focused on driving growth through AHSC expansion and revenue enhancement strategies.

Phreesia Inc reports robust Q3 earnings, eyes sustained growth

Phreesia Inc's Q3 performance reflects strong financial results and positive cash flows, underpinning its growth trajectory.
The company's revised outlooks for fiscal 2025 and initial guidance for 2026 signal confidence in sustained growth and profitability.
While balancing profitability and reinvestment poses challenges, Phreesia has opportunities to leverage network solutions, customer feedback, and strategic leadership for future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

NEWBURY PARK, Calif. & RALEIGH, N.C.--(BUSINESS WIRE)--Compulink Healthcare Solutions, a leader in specialty-specific all-in-one EHR solutions; and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce that they have partnered to offer a robust, bidirectional integration between their systems. This integration will help practices save time, increase patient collections, improve patient satisfaction, and keep their schedules full. Practices using Phreesia and Com

Compulink and Phreesia Partner to Help Practices Increase Efficiency and Profitability with an Integrated Intake Solution

Phreesia, Inc. (NYSE:PHR ) Q1 2023 Earnings Conference Call June 2, 2022 5:00 PM ET Company Participants Balaji Gandhi - Senior Vice President, Investor Relations Chaim Indig - Chief Executive Officer and Co-Founder Randy Rasmussen - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler John Ransom - Raymond James Joe Vruwink - Robert W. Baird Glen Santangelo - Jefferies Richard Close - Canaccord Genuity Ryan MacDonald - Needham Stephanie Davis - SVB Leerink Joe Goodwin - JMP Securities Jack Wallace - Guggenheim Operator Good afternoon.

Phreesia, Inc. (PHR) CEO Chaim Indig on Q1 2023 Results - Earnings Call Transcript

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2022. “We started the year strong with gains in new clients and expansion within existing clients across healthcare services and life sciences and began to generate operating leverage from our accelerated investments in fiscal years 2021 and 2022,” said CEO and Co-Founder Chaim Indig. Fiscal First Quarter 2023 Highlights Revenue

Phreesia Announces Fiscal First Quarter 2023 Results

Phreesia (PHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phreesia (PHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

SALT LAKE CITY & RALEIGH, N.C.--(BUSINESS WIRE)--KLAS, a healthcare research and insights firm, and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce the release of a report that aims to shed light on patients' preferences and expectations for the technology they interact with as a part of their healthcare experience. The report is the result of a survey designed to better understand patient sentiments on a range of topics, including how they like to schedul

KLAS and Phreesia Partner to Deliver Patient Insights on Healthcare Technology

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is excited to announce it has been selected by Becker's Healthcare as one of this year's 150 Top Places to Work in Healthcare. The list highlights hospitals, health systems and healthcare companies that promote diversity within the workforce, employee engagement and professional growth. “We're thrilled to receive this recognition of our commitment to maintaining a diverse, inclusive and equitable environment that supports employee growth and success,” sa

Phreesia Named One of Becker's Healthcare's “150 Top Places to Work in Healthcare”

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is excited to announce it has been selected by Modern Healthcare as one of the 2022 Best Places to Work in Healthcare. This is the sixth time Phreesia has been named to the list. “We are proud to be included on this prestigious list once again,” said Phreesia CEO Chaim Indig. “With our team of remote workers located across the country, this honor is a testament to our ability to stay connected with our colleagues and clients, and to our talented and hard

Phreesia Selected as One of Modern Healthcare's “Best Places to Work in Healthcare” for a Sixth Year

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named Danielle Lynch, Vice President, Client Experience, as one of the 2022 PM360 ELITE 100. The PM360 ELITE Awards recognize the most influential people in the healthcare and life sciences industry today, and honorees were chosen from a pool of more than 500 submissions across 20 categories. The PM360 editorial staff selected winners based on their career accomplis

Phreesia's Danielle Lynch Named a ‘Sales MVP' in PM360's ELITE 100

Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Phreesia (PHR) Surges 7%: Is This an Indication of Further Gains?

Phreesia was a pioneer in reducing patient visitation paperwork in the clinical practice setting with their Phreesia Pad. They targeted small clinics,

Phreesia: Their Time Has Passed

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2023 financial results after the close of market trading on Thursday, June 2, 2022. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results start

Phreesia Sets Release Date for Fiscal First Quarter 2023 Results

ATLANTA & RALEIGH, N.C.--(BUSINESS WIRE)--Azalea Health, a leading provider of cloud-based patient management and health IT solutions, and Phreesia, a leader in patient intake, outreach and activation, today announced a collaboration to offer a robust integration between their systems to enhance the overall intake experience. This integration will allow provider organizations to offer patients a seamless, convenient digital experience more efficiently, with the staff they have. “Azalea Health h

Azalea Health and Phreesia Partner to Offer an Integrated Intake Experience to Growing Network of Providers

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade MM+M has named Danielle Lynch, Vice President, Client Experience, to its Women to Watch class of 2022. Now in its seventh year, the program recognizes successful leaders and up-and-coming talent in the industry who have inspired their colleagues, showcased new ways of doing business and taken healthcare marketing to new heights. Lynch was chosen as one of just 25 women to receive this ye

Phreesia's Danielle Lynch Named One of MM+M's ‘Women to Watch' for 2022

Phreesia, Inc. (PHR) CEO Chaim Indig on Q4 2022 Results - Earnings Call Transcript

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2022. "Our organization has accomplished much to be proud of in fiscal year 2022, Phreesia's 17th year and our third as a public company," said CEO and Co-Founder Chaim Indig. "We experienced tremendous growth in our platform, our capabilities and our team, and we greatly appreciate our employees' hard work and

Phreesia Announces Fiscal Year Ended January 31, 2022 Results

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Phreesia (PHR) Soars 5.9%: Is Further Upside Left in the Stock?

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Wednesday, March 30, 2022, at 5:00 p.m. Eastern Time to discuss the Company's fiscal fourth quarter 2022 financial results. A press release announcing the fiscal fourth quarter financial results will be issued prior to the conference call, after the close of market trading, on Wednesday, March 30, 2022. To participate in the company's live conference call and webcast, please dial (888) 350-343

Phreesia Sets Release Date for Fiscal Fourth Quarter 2022 Results

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia (NYSE: PHR) is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2022 Best in KLAS: Software and Services,” KLAS recognized the healthcare IT and services companies who excel in helping healthcare professionals improve patient care. This is the fourth consecutive year that Phreesia has been recognized as the top-rated patient intake management vendor by KLA

Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is proud to announce that Amy VanDuyn, the company's SVP of Human Resources, has been named a Top 10 HR Professional at the 2022 OnCon Icon Awards. The awards recognize the top human resources professionals and vendors worldwide. The honorees were selected based on voting by peers in the industry, using criteria such as leadership, innovation, and contributions to their organization and professional community. VanDuyn has more than 20 years of human reso

Phreesia's Amy VanDuyn Named a Top 10 HR Professional at the OnCon Icon Awards

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that it is one of 418 companies across 45 countries and regions to join the 2022 Bloomberg Gender-Equality Index (GEI). This reference index measures gender equality across five pillars: female leadership and talent pipeline, equal pay and gender pay parity, inclusive culture, anti-sexual harassment policies and pro-women brand. This is the second year in a row Phreesia has been included in the GEI, reflecting the organization's co

Phreesia Included in the 2022 Bloomberg Gender-Equality Index for the Second Year

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that it is now a part of MEDITECH Greenfield, a testing ground for apps that can integrate with MEDITECH Expanse. This collaboration with MEDITECH will allow Phreesia to better enable patients to take a more active role in their care. Through the Greenfield program, Phreesia seeks to: Enable API-based integration between MEDITECH and Phreesia, bringing even greater value to our shared clients Proactively notify patients about gaps

Phreesia Joins Greenfield, MEDITECH's Application Developer Environment

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named PatientInsights, Phreesia Life Sciences' market research platform, to its list of 2021 Most Innovative Services. Over the last decade, PM360's annual Innovations Issue has spotlighted the pharma industry's most innovative companies, products, strategies, services and more. PatientInsights was one of 52 overall honorees, chosen from hundreds of submissions, and

Phreesia Life Sciences' PatientInsights Named one of PM360's 2021 Most Innovative Services

Phreesia will benefit from multiple secular healthcare trends.

Opportunistic Time To Buy Phreesia's Healthcare Disruption

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that the healthcare marketing industry trade publication Medical Marketing and Media (MM+M) has named Phreesia Life Sciences to its list of Best Places to Work 2021. Now in its fourth year, the annual review spotlights the top healthcare marketing agencies and service providers that support the life sciences industry as rated by employees themselves. Phreesia was one of just two companies recognized in the “Large Companies/Service

Phreesia Life Sciences Named one of MM+M's “Best Places to Work 2021”

RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is excited to announce it has acquired Insignia Health, LLC, a founder-led and mission-oriented company dedicated to improving health outcomes through patient activation. The acquisition is a natural extension of Phreesia's commitment to enabling patients to become more active participants in their care. “Phreesia's core strength is putting tools in the hands of patients to take on tasks—from self-reporting data like social determinants of health to maki

News for Phreesia Inc Stock (PHR)